From: Lessons learned in the development of process quality indicators for cancer care in Japan
Denominator (target patients) | Numerator (care processes indicated) |
---|---|
Patients with stage 3 colorectal cancer who have undergone surgical resection | Patients who have received standard chemotherapy within 8 weeks of surgery or who have reasons for not receiving chemotherapy |
Patients with colorectal cancer who have undergone surgical resection | Patients who have received total colonoscopy or who have reasons for not receiving total colonoscopy |
Patients with gastric cancer who have undergone endoscopic resection and have one of the following: • positive vertical margin • lymphovascular invasion • invasion to the SM2 layer (≥500 μm) | Patients who have received surgical treatment with lymph-node dissection |
Patients diagnosed with breast cancer | Patients who have had their Her-2/neu status examined |
Patients receiving treatment for liver cancer | Patients who have had the levels of α-fetoprotein and protein in vitamin K absence-II checked before the start of therapy |
Patient with lung cancer who have undergone surgical resection or radiation therapy on their lungs | Patients whose lung function has been assessed via spirometry |
Patient receiving narcotic analgesics | Patients who have received education or medication to prevent constipation |